Citation Impact
Citing Papers
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
2008 StandoutScience
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Sporadic and hereditary amyotrophic lateral sclerosis (ALS)
2014
Long Patch Base Excision Repair Proceeds via Coordinated Stimulation of the Multienzyme DNA Repair Complex
2009 StandoutNobel
Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis
2007
Inflammatory processes in amyotrophic lateral sclerosis
2002
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
2008
Diagnosis of amyotrophic lateral sclerosis
1998
Incidence of amyotrophic lateral sclerosis in Europe
2009
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives
2009
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
“True” sporadic ALS associated with a novel SOD‐1 mutation
2002
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
2005 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
2006 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
2005
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Mitochondrial DNA mutations in human degenerative diseases and aging
1995
Genetics, epigenetics and pharmaco‐(epi)genomics in angiogenesis
2008
Phenotypic heterogeneity in motor neuron disease patients with CuZn- superoxide dismutase mutations in Scandinavia
1997
Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence‐based review with good practice points. EALSC Working Group
2007
Mitochondrial diabetes mellitus: a review
1995
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
2006
Maternal Age, Exposure to Siblings, and Risk of Amyotrophic Lateral Sclerosis
2008
The Role of Immune and Inflammatory Mechanisms in ALS
2011
Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
2009
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2003
Amyotrophic lateral sclerosis
2011 Standout
The prevalence of multiple sclerosis in the world: an update
2001
Diagnosis of multiple sclerosis: progress and challenges
2016
Amyotrophic Lateral Sclerosis Mimic Syndromes
2000
Cognitive impairment in amyotrophic lateral sclerosis
2007
Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis
1997
The management of motor neurone disease
2003
Multiple sclerosis
2008 Standout
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS
1996
Decoding ALS: from genes to mechanism
2016 StandoutNature
Biomarkers in amyotrophic lateral sclerosis
2008
Amyotrophic lateral sclerosis: A 40-year personal perspective
2009
Principal components analysis corrects for stratification in genome-wide association studies
2006 Standout
Diabetic Retinopathy
2012 Standout
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
2006
Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
2008
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial
2006
The epidemiology of multiple sclerosis
2016
Control of Motoneuron Survival by Angiogenin
2008
Inflammatory Bowel Disease
2002 Standout
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
2007
Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin
2003
Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes
2000
Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders
2000
Misregulated RNA processing in amyotrophic lateral sclerosis
2012
Three or more routes for leukocyte migration into the central nervous system
2003
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Alzheimer's disease
2006 Standout
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
1998 Standout
The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia
2000
Ageing-induced decline in physical endurance in mice is associated with decrease in cardiac SUR2A and increase in cardiac susceptibility to metabolic stress: therapeutic prospects for up-regulation of SUR2A
2010
Defining Disease Activity and Response to Therapy in MS
2017
HLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
1991
Alzheimer's Disease
2010 Standout
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
Clinical Trials of Transplant Tolerance: Slow But Steady Progress
2003
ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis
1999
Progress in the pathogenesis of amyotrophic lateral sclerosis
2001
A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation
2015 Standout
Multiple Sclerosis
2000 Standout
Physical activity as an exogenous risk factor in motor neuron disease (MND): A review of the evidence
2009
Epidemiology of Multiple Sclerosis: A Critical Overview
1993
The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA
2001
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives
2005
A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease
2001
Environmental risk factors in multiple sclerosis aetiology
2004
Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
2005
Search for persistent infection with poliovirus or other enteroviruses in amyotrophic lateral sclerosis-motor neurone disease
1995
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases
2020 StandoutNobel
Novel drug development for amyotrophic lateral sclerosis
2000
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists
2002
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease?
2007
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk
2001
Neurovascular signalling defects in neurodegeneration
2008
Multiple sclerosis
2002 Standout
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Can a Ketone Be More Reactive than an Aldehyde? Catalytic Asymmetric Synthesis of Substituted Tetrahydrofurans
2018 StandoutNobel
EPIDEMIOLOGY OF NEURODEGENERATION
2003
MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
2018
Integrin–Matrix Interactions in the Cerebral Microvasculature
2006
Copper Active Sites in Biology
2014 Standout
Multiple Sclerosis
2018 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Epidemiologic evidence for multiple sclerosis as an infection
1993
Anti-α4 integrin therapy for multiple sclerosis
2005
Reduced frequency of ALS in an ethnically mixed population
2009
Spermidine in health and disease
2018 StandoutScience
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Mitochondrial Diseases in Man and Mouse
1999 StandoutScience
Epidemiology of multiple sclerosis in Australia: With NSW and SA survey results
1994
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment
2000
Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43
2012
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.
1996
Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress
1997 Standout
Clinical presentation and diagnosis of Amyotrophic Lateral Sclerosis
2007
Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.
2000
Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis
2009
Ethnic variation in the incidence of ALS
2007
APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination
2014 StandoutNobel
Assessment of disease progression in motor neuron disease
2005
COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS
2003
How common are the “common” neurologic disorders?
2007
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
1999
Works of Robert Swingler being referenced
HLA and multiple sclerosis in south east Wales.
1987
Amyotrophic lateral sclerosis, physical exercise, trauma and sports: Results of a population-based pilot case-control study
2010
The incidence of motor nueron disease in Scotland
2007
The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials
2010
The epidemiology of ALS and the role of population-based registries
2006
Survival and cause of death in multiple sclerosis: a prospective population-based study
2008
Are the El Escorial and Revised El Escorial criteria for ALS reproducible? A study of inter-observer agreement
2001
The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?
1999
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
2006
Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus
1993
Identification of a novel S0D1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of lle113Thr in three others
1994
A Patient Suffering from Hypokalemic Periodic Paralysis Is Deficient in Skeletal Muscle ATP‐sensitive K+ channels
2008
Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis
2008
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
2007
The Heterogeneity of Amyotrophic Lateral Sclerosis: A Possible Explanation of Treatment Failure
2007
Increasing prevalence and incidence of multiple sclerosis in South East Wales
2008
The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register
1993
Demographic Characteristics of Multiple Sclerosis in South East Wales
1990
CuZn-Superoxide Dismutase in D90A Heterozygotes from Recessive and Dominant ALS Pedigrees
2002
Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis
2008
The distribution of multiple sclerosis in the United Kingdom.
1986
Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis
1999
The effect of anti-α4 integrin antibody on brain lesion activity in MS
1999
The prevalence of multiple sclerosis in south east Wales.
1988
Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients.
1995
The incidence and mortality of multiple sclerosis in south east Wales.
1989
Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register.
1996
Motor neuron disease and polio in Scotland.
1992
Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.
1993